Global Nonalcoholic Fatty Liver Disease Market Research Report 2016

Publisher Name :
Date: 07-Sep-2016
No. of pages: 107
Inquire Before Buying

Notes:

Production, means the output of Nonalcoholic Fatty Liver Disease

Revenue, means the sales value of Nonalcoholic Fatty Liver Disease

This report studies Nonalcoholic Fatty Liver Disease in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with Production, price, revenue and market share for each manufacturer, covering

- Conatus Pharmaceuticals

- Daewoong Pharmaceutical

- Galmed International

- Kyorin Pharmaceutical

- Metabolic Solutions Development

- Novartis AG

- Phenex Pharmaceuticals

- Raptor Pharmaceuticals

- TCM Biotech International

- Tobira Therapeutics

Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth rate of Nonalcoholic Fatty Liver Disease in these regions, from 2011 to 2021 (forecast), like

- North America

- Europe

- China

- Japan

- Southeast Asia

- India

Split by product type, with production, revenue, price, market share and growth rate of each type, can be divided into

- Type I

- Type II

- Type III

Split by application, this report focuses on consumption, market share and growth rate of Nonalcoholic Fatty Liver Disease in each application, can be divided into

- Application 1

- Application 2

- Application 3

Global Nonalcoholic Fatty Liver Disease Market Research Report 2016

Table of Contents
Global Nonalcoholic Fatty Liver Disease Market Research Report 2016
1 Nonalcoholic Fatty Liver Disease Market Overview
1.1 Product Overview and Scope of Nonalcoholic Fatty Liver Disease
1.2 Nonalcoholic Fatty Liver Disease Segment by Type
1.2.1 Global Production Market Share of Nonalcoholic Fatty Liver Disease by Type in 2015
1.2.2 Type I
1.2.3 Type II
1.2.4 Type III
1.3 Nonalcoholic Fatty Liver Disease Segment by Application
1.3.1 Nonalcoholic Fatty Liver Disease Consumption Market Share by Application in 2015
1.3.2 Application 1
1.3.3 Application 2
1.3.4 Application 3
1.4 Nonalcoholic Fatty Liver Disease Market by Region
1.4.1 North America Status and Prospect (2011-2021)
1.4.2 Europe Status and Prospect (2011-2021)
1.4.3 China Status and Prospect (2011-2021)
1.4.4 Japan Status and Prospect (2011-2021)
1.4.5 Southeast Asia Status and Prospect (2011-2021)
1.4.6 India Status and Prospect (2011-2021)
1.5 Global Market Size (Value) of Nonalcoholic Fatty Liver Disease (2011-2021)
2 Global Nonalcoholic Fatty Liver Disease Market Competition by Manufacturers
2.1 Global Nonalcoholic Fatty Liver Disease Production and Share by Manufacturers (2015 and 2016)
2.2 Global Nonalcoholic Fatty Liver Disease Revenue and Share by Manufacturers (2015 and 2016)
2.3 Global Nonalcoholic Fatty Liver Disease Average Price by Manufacturers (2015 and 2016)
2.4 Manufacturers Nonalcoholic Fatty Liver Disease Manufacturing Base Distribution, Sales Area and Product Type
2.5 Nonalcoholic Fatty Liver Disease Market Competitive Situation and Trends
2.5.1 Nonalcoholic Fatty Liver Disease Market Concentration Rate
2.5.2 Nonalcoholic Fatty Liver Disease Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion
3 Global Nonalcoholic Fatty Liver Disease Production, Revenue (Value) by Region (2011-2016)
3.1 Global Nonalcoholic Fatty Liver Disease Production and Market Share by Region (2011-2016)
3.2 Global Nonalcoholic Fatty Liver Disease Revenue (Value) and Market Share by Region (2011-2016)
3.3 Global Nonalcoholic Fatty Liver Disease Production, Revenue, Price and Gross Margin (2011-2016)
3.4 North America Nonalcoholic Fatty Liver Disease Production, Revenue, Price and Gross Margin (2011-2016)
3.5 Europe Nonalcoholic Fatty Liver Disease Production, Revenue, Price and Gross Margin (2011-2016)
3.6 China Nonalcoholic Fatty Liver Disease Production, Revenue, Price and Gross Margin (2011-2016)
3.7 Japan Nonalcoholic Fatty Liver Disease Production, Revenue, Price and Gross Margin (2011-2016)
3.8 Southeast Asia Nonalcoholic Fatty Liver Disease Production, Revenue, Price and Gross Margin (2011-2016)
3.9 India Nonalcoholic Fatty Liver Disease Production, Revenue, Price and Gross Margin (2011-2016)
4 Global Nonalcoholic Fatty Liver Disease Supply (Production), Consumption, Export, Import by Regions (2011-2016)
4.1 Global Nonalcoholic Fatty Liver Disease Consumption by Regions (2011-2016)
4.2 North America Nonalcoholic Fatty Liver Disease Production, Consumption, Export, Import by Regions (2011-2016)
4.3 Europe Nonalcoholic Fatty Liver Disease Production, Consumption, Export, Import by Regions (2011-2016)
4.4 China Nonalcoholic Fatty Liver Disease Production, Consumption, Export, Import by Regions (2011-2016)
4.5 Japan Nonalcoholic Fatty Liver Disease Production, Consumption, Export, Import by Regions (2011-2016)
4.6 Southeast Asia Nonalcoholic Fatty Liver Disease Production, Consumption, Export, Import by Regions (2011-2016)
4.7 India Nonalcoholic Fatty Liver Disease Production, Consumption, Export, Import by Regions (2011-2016)
5 Global Nonalcoholic Fatty Liver Disease Production, Revenue (Value), Price Trend by Type
5.1 Global Nonalcoholic Fatty Liver Disease Production and Market Share by Type (2011-2016)
5.2 Global Nonalcoholic Fatty Liver Disease Revenue and Market Share by Type (2011-2016)
5.3 Global Nonalcoholic Fatty Liver Disease Price by Type (2011-2016)
5.4 Global Nonalcoholic Fatty Liver Disease Production Growth by Type (2011-2016)
6 Global Nonalcoholic Fatty Liver Disease Market Analysis by Application
6.1 Global Nonalcoholic Fatty Liver Disease Consumption and Market Share by Application (2011-2016)
6.2 Global Nonalcoholic Fatty Liver Disease Consumption Growth Rate by Application (2011-2016)
6.3 Market Drivers and Opportunities
6.3.1 Potential Applications
6.3.2 Emerging Markets/Countries
7 Global Nonalcoholic Fatty Liver Disease Manufacturers Profiles/Analysis
7.1 Conatus Pharmaceuticals
7.1.1 Company Basic Information, Manufacturing Base and Its Competitors
7.1.2 Nonalcoholic Fatty Liver Disease Product Type, Application and Specification
7.1.2.1 Type I
7.1.2.2 Type II
7.1.3 Conatus Pharmaceuticals Nonalcoholic Fatty Liver Disease Production, Revenue, Price and Gross Margin (2015 and 2016)
7.1.4 Main Business/Business Overview
7.2 Daewoong Pharmaceutical
7.2.1 Company Basic Information, Manufacturing Base and Its Competitors
7.2.2 Nonalcoholic Fatty Liver Disease Product Type, Application and Specification
7.2.2.1 Type I
7.2.2.2 Type II
7.2.3 Daewoong Pharmaceutical Nonalcoholic Fatty Liver Disease Production, Revenue, Price and Gross Margin (2015 and 2016)
7.2.4 Main Business/Business Overview
7.3 Galmed International
7.3.1 Company Basic Information, Manufacturing Base and Its Competitors
7.3.2 Nonalcoholic Fatty Liver Disease Product Type, Application and Specification
7.3.2.1 Type I
7.3.2.2 Type II
7.3.3 Galmed International Nonalcoholic Fatty Liver Disease Production, Revenue, Price and Gross Margin (2015 and 2016)
7.3.4 Main Business/Business Overview
7.4 Kyorin Pharmaceutical
7.4.1 Company Basic Information, Manufacturing Base and Its Competitors
7.4.2 Nonalcoholic Fatty Liver Disease Product Type, Application and Specification
7.4.2.1 Type I
7.4.2.2 Type II
7.4.3 Kyorin Pharmaceutical Nonalcoholic Fatty Liver Disease Production, Revenue, Price and Gross Margin (2015 and 2016)
7.4.4 Main Business/Business Overview
7.5 Metabolic Solutions Development
7.5.1 Company Basic Information, Manufacturing Base and Its Competitors
7.5.2 Nonalcoholic Fatty Liver Disease Product Type, Application and Specification
7.5.2.1 Type I
7.5.2.2 Type II
7.5.3 Metabolic Solutions Development Nonalcoholic Fatty Liver Disease Production, Revenue, Price and Gross Margin (2015 and 2016)
7.5.4 Main Business/Business Overview
7.6 Novartis AG
7.6.1 Company Basic Information, Manufacturing Base and Its Competitors
7.6.2 Nonalcoholic Fatty Liver Disease Product Type, Application and Specification
7.6.2.1 Type I
7.6.2.2 Type II
7.6.3 Novartis AG Nonalcoholic Fatty Liver Disease Production, Revenue, Price and Gross Margin (2015 and 2016)
7.6.4 Main Business/Business Overview
7.7 Phenex Pharmaceuticals
7.7.1 Company Basic Information, Manufacturing Base and Its Competitors
7.7.2 Nonalcoholic Fatty Liver Disease Product Type, Application and Specification
7.7.2.1 Type I
7.7.2.2 Type II
7.7.3 Phenex Pharmaceuticals Nonalcoholic Fatty Liver Disease Production, Revenue, Price and Gross Margin (2015 and 2016)
7.7.4 Main Business/Business Overview
7.8 Raptor Pharmaceuticals
7.8.1 Company Basic Information, Manufacturing Base and Its Competitors
7.8.2 Nonalcoholic Fatty Liver Disease Product Type, Application and Specification
7.8.2.1 Type I
7.8.2.2 Type II
7.8.3 Raptor Pharmaceuticals Nonalcoholic Fatty Liver Disease Production, Revenue, Price and Gross Margin (2015 and 2016)
7.8.4 Main Business/Business Overview
7.9 TCM Biotech International
7.9.1 Company Basic Information, Manufacturing Base and Its Competitors
7.9.2 Nonalcoholic Fatty Liver Disease Product Type, Application and Specification
7.9.2.1 Type I
7.9.2.2 Type II
7.9.3 TCM Biotech International Nonalcoholic Fatty Liver Disease Production, Revenue, Price and Gross Margin (2015 and 2016)
7.9.4 Main Business/Business Overview
7.10 Tobira Therapeutics
7.10.1 Company Basic Information, Manufacturing Base and Its Competitors
7.10.2 Nonalcoholic Fatty Liver Disease Product Type, Application and Specification
7.10.2.1 Type I
7.10.2.2 Type II
7.10.3 Tobira Therapeutics Nonalcoholic Fatty Liver Disease Production, Revenue, Price and Gross Margin (2015 and 2016)
7.10.4 Main Business/Business Overview
8 Nonalcoholic Fatty Liver Disease Manufacturing Cost Analysis
8.1 Nonalcoholic Fatty Liver Disease Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Nonalcoholic Fatty Liver Disease
9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 Nonalcoholic Fatty Liver Disease Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Nonalcoholic Fatty Liver Disease Major Manufacturers in 2015
9.4 Downstream Buyers
10 Marketing Strategy Analysis, Distributors/Traders
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
11 Market Effect Factors Analysis
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change
12 Global Nonalcoholic Fatty Liver Disease Market Forecast (2016-2021)
12.1 Global Nonalcoholic Fatty Liver Disease Production, Revenue Forecast (2016-2021)
12.2 Global Nonalcoholic Fatty Liver Disease Production, Consumption Forecast by Regions (2016-2021)
12.3 Global Nonalcoholic Fatty Liver Disease Production Forecast by Type (2016-2021)
12.4 Global Nonalcoholic Fatty Liver Disease Consumption Forecast by Application (2016-2021)
12.5 Nonalcoholic Fatty Liver Disease Price Forecast (2016-2021)
13 Research Findings and Conclusion
14 Appendix
Author List
Disclosure Section
Research Methodology
Data Source
China Disclaimer
List of Tables and Figures
Figure Picture of Nonalcoholic Fatty Liver Disease
Figure Global Production Market Share of Nonalcoholic Fatty Liver Disease by Type in 2015
Figure Product Picture of Type I
Table Major Manufacturers of Type I
Figure Product Picture of Type II
Table Major Manufacturers of Type II
Figure Product Picture of Type III
Table Major Manufacturers of Type III
Table Nonalcoholic Fatty Liver Disease Consumption Market Share by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure Application 3 Examples
Figure North America Nonalcoholic Fatty Liver Disease Revenue (Million USD) and Growth Rate (2011-2021)
Figure Europe Nonalcoholic Fatty Liver Disease Revenue (Million USD) and Growth Rate (2011-2021)
Figure China Nonalcoholic Fatty Liver Disease Revenue (Million USD) and Growth Rate (2011-2021)
Figure Japan Nonalcoholic Fatty Liver Disease Revenue (Million USD) and Growth Rate (2011-2021)
Figure Southeast Asia Nonalcoholic Fatty Liver Disease Revenue (Million USD) and Growth Rate (2011-2021)
Figure India Nonalcoholic Fatty Liver Disease Revenue (Million USD) and Growth Rate (2011-2021)
Figure Global Nonalcoholic Fatty Liver Disease Revenue (Million UDS) and Growth Rate (2011-2021)
Table Global Nonalcoholic Fatty Liver Disease Production of Key Manufacturers (2015 and 2016)
Table Global Nonalcoholic Fatty Liver Disease Production Share by Manufacturers (2015 and 2016)
Figure 2015 Nonalcoholic Fatty Liver Disease Production Share by Manufacturers
Figure 2016 Nonalcoholic Fatty Liver Disease Production Share by Manufacturers
Table Global Nonalcoholic Fatty Liver Disease Revenue (Million USD) by Manufacturers (2015 and 2016)
Table Global Nonalcoholic Fatty Liver Disease Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Global Nonalcoholic Fatty Liver Disease Revenue Share by Manufacturers
Table 2016 Global Nonalcoholic Fatty Liver Disease Revenue Share by Manufacturers
Table Global Market Nonalcoholic Fatty Liver Disease Average Price of Key Manufacturers (2015 and 2016)
Figure Global Market Nonalcoholic Fatty Liver Disease Average Price of Key Manufacturers in 2015
Table Manufacturers Nonalcoholic Fatty Liver Disease Manufacturing Base Distribution and Sales Area
Table Manufacturers Nonalcoholic Fatty Liver Disease Product Type
Figure Nonalcoholic Fatty Liver Disease Market Share of Top 3 Manufacturers
Figure Nonalcoholic Fatty Liver Disease Market Share of Top 5 Manufacturers
Table Global Nonalcoholic Fatty Liver Disease Production by Regions (2011-2016)
Figure Global Nonalcoholic Fatty Liver Disease Production and Market Share by Regions (2011-2016)
Figure Global Nonalcoholic Fatty Liver Disease Production Market Share by Regions (2011-2016)
Figure 2015 Global Nonalcoholic Fatty Liver Disease Production Market Share by Regions
Table Global Nonalcoholic Fatty Liver Disease Revenue by Regions (2011-2016)
Table Global Nonalcoholic Fatty Liver Disease Revenue Market Share by Regions (2011-2016)
Table 2015 Global Nonalcoholic Fatty Liver Disease Revenue Market Share by Regions
Table Global Nonalcoholic Fatty Liver Disease Production, Revenue, Price and Gross Margin (2011-2016)
Table North America Nonalcoholic Fatty Liver Disease Production, Revenue, Price and Gross Margin (2011-2016)
Table Europe Nonalcoholic Fatty Liver Disease Production, Revenue, Price and Gross Margin (2011-2016)
Table China Nonalcoholic Fatty Liver Disease Production, Revenue, Price and Gross Margin (2011-2016)
Table Japan Nonalcoholic Fatty Liver Disease Production, Revenue, Price and Gross Margin (2011-2016)
Table Southeast Asia Nonalcoholic Fatty Liver Disease Production, Revenue, Price and Gross Margin (2011-2016)
Table India Nonalcoholic Fatty Liver Disease Production, Revenue, Price and Gross Margin (2011-2016)
Table Global Nonalcoholic Fatty Liver Disease Consumption Market by Regions (2011-2016)
Table Global Nonalcoholic Fatty Liver Disease Consumption Market Share by Regions (2011-2016)
Figure Global Nonalcoholic Fatty Liver Disease Consumption Market Share by Regions (2011-2016)
Figure 2015 Global Nonalcoholic Fatty Liver Disease Consumption Market Share by Regions
Table North America Nonalcoholic Fatty Liver Disease Production, Consumption, Import & Export (2011-2016)
Table Europe Nonalcoholic Fatty Liver Disease Production, Consumption, Import & Export (2011-2016)
Table China Nonalcoholic Fatty Liver Disease Production, Consumption, Import & Export (2011-2016)
Table Japan Nonalcoholic Fatty Liver Disease Production, Consumption, Import & Export (2011-2016)
Table Southeast Asia Nonalcoholic Fatty Liver Disease Production, Consumption, Import & Export (2011-2016)
Table India Nonalcoholic Fatty Liver Disease Production, Consumption, Import & Export (2011-2016)
Table Global Nonalcoholic Fatty Liver Disease Production by Type (2011-2016)
Table Global Nonalcoholic Fatty Liver Disease Production Share by Type (2011-2016)
Figure Production Market Share of Nonalcoholic Fatty Liver Disease by Type (2011-2016)
Figure 2015 Production Market Share of Nonalcoholic Fatty Liver Disease by Type
Table Global Nonalcoholic Fatty Liver Disease Revenue by Type (2011-2016)
Table Global Nonalcoholic Fatty Liver Disease Revenue Share by Type (2011-2016)
Figure Production Revenue Share of Nonalcoholic Fatty Liver Disease by Type (2011-2016)
Figure 2015 Revenue Market Share of Nonalcoholic Fatty Liver Disease by Type
Table Global Nonalcoholic Fatty Liver Disease Price by Type (2011-2016)
Figure Global Nonalcoholic Fatty Liver Disease Production Growth by Type (2011-2016)
Table Global Nonalcoholic Fatty Liver Disease Consumption by Application (2011-2016)
Table Global Nonalcoholic Fatty Liver Disease Consumption Market Share by Application (2011-2016)
Figure Global Nonalcoholic Fatty Liver Disease Consumption Market Share by Application in 2015
Table Global Nonalcoholic Fatty Liver Disease Consumption Growth Rate by Application (2011-2016)
Figure Global Nonalcoholic Fatty Liver Disease Consumption Growth Rate by Application (2011-2016)
Table Conatus Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Conatus Pharmaceuticals Nonalcoholic Fatty Liver Disease Production, Revenue, Price and Gross Margin (2011-2016)
Figure Conatus Pharmaceuticals Nonalcoholic Fatty Liver Disease Market Share (2011-2016)
Table Daewoong Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Daewoong Pharmaceutical Nonalcoholic Fatty Liver Disease Production, Revenue, Price and Gross Margin (2011-2016)
Figure Daewoong Pharmaceutical Nonalcoholic Fatty Liver Disease Market Share (2011-2016)
Table Galmed International Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Galmed International Nonalcoholic Fatty Liver Disease Production, Revenue, Price and Gross Margin (2011-2016)
Figure Galmed International Nonalcoholic Fatty Liver Disease Market Share (2011-2016)
Table Kyorin Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Kyorin Pharmaceutical Nonalcoholic Fatty Liver Disease Production, Revenue, Price and Gross Margin (2011-2016)
Figure Kyorin Pharmaceutical Nonalcoholic Fatty Liver Disease Market Share (2011-2016)
Table Metabolic Solutions Development Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Metabolic Solutions Development Nonalcoholic Fatty Liver Disease Production, Revenue, Price and Gross Margin (2011-2016)
Figure Metabolic Solutions Development Nonalcoholic Fatty Liver Disease Market Share (2011-2016)
Table Novartis AG Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novartis AG Nonalcoholic Fatty Liver Disease Production, Revenue, Price and Gross Margin (2011-2016)
Figure Novartis AG Nonalcoholic Fatty Liver Disease Market Share (2011-2016)
Table Phenex Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Phenex Pharmaceuticals Nonalcoholic Fatty Liver Disease Production, Revenue, Price and Gross Margin (2011-2016)
Figure Phenex Pharmaceuticals Nonalcoholic Fatty Liver Disease Market Share (2011-2016)
Table Raptor Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Raptor Pharmaceuticals Nonalcoholic Fatty Liver Disease Production, Revenue, Price and Gross Margin (2011-2016)
Figure Raptor Pharmaceuticals Nonalcoholic Fatty Liver Disease Market Share (2011-2016)
Table TCM Biotech International Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table TCM Biotech International Nonalcoholic Fatty Liver Disease Production, Revenue, Price and Gross Margin (2011-2016)
Figure TCM Biotech International Nonalcoholic Fatty Liver Disease Market Share (2011-2016)
Table Tobira Therapeutics Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Tobira Therapeutics Nonalcoholic Fatty Liver Disease Production, Revenue, Price and Gross Margin (2011-2016)
Figure Tobira Therapeutics Nonalcoholic Fatty Liver Disease Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Nonalcoholic Fatty Liver Disease
Figure Manufacturing Process Analysis of Nonalcoholic Fatty Liver Disease
Figure Nonalcoholic Fatty Liver Disease Industrial Chain Analysis
Table Raw Materials Sources of Nonalcoholic Fatty Liver Disease Major Manufacturers in 2015
Table Major Buyers of Nonalcoholic Fatty Liver Disease
Table Distributors/Traders List
Figure Global Nonalcoholic Fatty Liver Disease Production and Growth Rate Forecast (2016-2021)
Figure Global Nonalcoholic Fatty Liver Disease Revenue and Growth Rate Forecast (2016-2021)
Table Global Nonalcoholic Fatty Liver Disease Production Forecast by Regions (2016-2021)
Table Global Nonalcoholic Fatty Liver Disease Consumption Forecast by Regions (2016-2021)
Table Global Nonalcoholic Fatty Liver Disease Production Forecast by Type (2016-2021)
Table Global Nonalcoholic Fatty Liver Disease Consumption Forecast by Application (2016-2021)
  • Renewable Energy Sources Needs To Boost Global Microgrids Market
    The global market for microgrid was worth US$13.3 billion in 2015, and is anticipated to touch an estimate of US$35.2 billion by 2020. Dealers in the market for microgrids are incessantly improving the network hosting capability for renewable energy resources to excerpt an extreme amount from it, in addition to commercialization of classically costly renewable […]
  • Manufacturing Trends In The Coming Days
    The manufacturing industry may be encountering some breezes, but it is irrefutably in the middle of a technological revival that is altering the appearance, structures, and practices of the modern factory. Notwithstanding the jeopardies and in spite of recent history industrial manufacturing enterprises cannot afford to disregard these developments. Few of the trends to look […]
  • Top 10 Emerging Technologies
    The World Economic Forum (WEF) and Scientific American lately unveiled the major technological innovation list of the top ten emerging technologies. This list emphasizes on the technological developments which have the supremacy to transform industries, protect the planet, and improve lives. It also presents an opening to discuss any societal, human, economic or environmental jeopardies […]
  • Global Biosimilars Market To Be Led By Novartis by 2020
    Biologics, which are typically inoculated or injected, are formed in living entities, making them more challenging and costly to manufacture than the usual pills contrived from chemicals. Observing that mock-ups are mostly identical to the prototypes has also modelled specific scientific and regulatory tasks. But the US FDA and European supervisors lately have acknowledged new […]
  • Global Thyroid Gland Disorder Treatment Market To Grow Steadily
    The global thyroid gland disorder treatment market was worth US$1.8 billion in 2014 and is projected to reach a market value of US$2.4 billion in 2023 intensifying at a CAGR of 3.1% from 2015 to 2023.  The thyroid gland produces thyroid hormones that control some of the most essential functions in the human body such as stimulating […]
  • Global Vegetable (HPMC) Capsule Market by Manufacturers, Countries, Type and Application, Forecast to 2022
    Published: 26-May-2017        Price: US 3480 Onwards        Pages: 116
    Hydroxypropyl methylcellulose is a methylcellulose modified with a small amount of propylene glycol ether groups attached to the anhydroglucose of the cellulose. HPMC Capsules are two-piece capsules made from cellulosic raw materials that satisfy vegetarian, religion, cultural and policy needs. These vegetable capsules are an attractive, all natural dosage form that retain all the advantages - easy to swallow, effectively mask taste and odor, and allow product visibility. These ca......
  • North America Vegetable (HPMC) Capsule Market by Manufacturers, Countries, Type and Application, Forecast to 2022
    Published: 26-May-2017        Price: US 4480 Onwards        Pages: 116
    Hydroxypropyl methylcellulose is a methylcellulose modified with a small amount of propylene glycol ether groups attached to the anhydroglucose of the cellulose. HPMC Capsules are two-piece capsules made from cellulosic raw materials that satisfy vegetarian, religion, cultural and policy needs. These vegetable capsules are an attractive, all natural dosage form that retain all the advantages - easy to swallow, effectively mask taste and odor, and allow product visibility. These ca......
  • Global Compounding Pharmacy Market by Manufacturers, Countries, Type and Application, Forecast to 2022
    Published: 25-May-2017        Price: US 3480 Onwards        Pages: 116
    The traditional role of compounding pharmacies is to make drugs prescribed by doctors for specific patients with needs that can't be met by commercially available drugs. For example: A young child may need a small, liquid dose of a drug made only in adult-dosage tablets. A person may be allergic to one of the ingredients in the commercial version of a drug. A compounding pharmacy would make the proper dosage and form of the drug without any offending ......
  • Global Foot and Mouth Disease (FMD) Vaccines Market Research Report 2017
    Published: 24-May-2017        Price: US 2900 Onwards        Pages: 127
    In this report, the global Foot and Mouth Disease (FMD) Vaccines market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Foot and Mouth Disease (FMD) Vaccines in these regions, from 2012 to 2022 (forecast), covering - North America......
  • Global Tourniquet Market Research Report 2017
    Published: 24-May-2017        Price: US 2900 Onwards        Pages: 110
    In this report, the global Tourniquet market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Tourniquet in these regions, from 2012 to 2022 (forecast), covering - North America - Europe - China - Japan ......
  • 2017-2022 China Liquid Biopsy Products Market Report (Status and Outlook)
    Published: 24-May-2017        Price: US 3360 Onwards        Pages: 119
    "This report will be delivered in 2-3 business days after the order is placed." The Liquid Biopsy Products market size will be XX million (USD) in 2022 in China, from the XX million (USD) in 2016, with a CAGR (Compound Annual Growth Rate) XX% from 2016 to 2022. In China market, the top players include - RainDanceTechnologies - Biocartis - Qiagen - Guardant Health - MDxHealth - Pathway Genomics - NeoGe......
  • Global Solid Organ Transplant Immunosuppressant Market Research Report 2017
    Published: 24-May-2017        Price: US 2900 Onwards        Pages: 109
    In this report, the global Solid Organ Transplant Immunosuppressant market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Solid Organ Transplant Immunosuppressant in these regions, from 2012 to 2022 (forecast), covering - North A......
  • Global Sufentanil (API) Market Research Report 2017
    Published: 24-May-2017        Price: US 2900 Onwards        Pages: 102
    In this report, the global Sufentanil (API) market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Sufentanil (API) in these regions, from 2012 to 2022 (forecast), covering - North America - Europe - China - J......
  • Global Communicable Diseases Treatment Market Size, Status and Forecast 2022
    Published: 24-May-2017        Price: US 3300 Onwards        Pages: 106
    This report studies the global Communicable Diseases Treatment market, analyzes and researches the Communicable Diseases Treatment development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like - Bristol-Myers Squibb Pharmaceutical - Eli Lilly - GlaxoSmithKline - Johnson & Johnson - Medtronic - Merck - Pfizer - F. Hoffmann-La Roche - Sanofi......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs